Emerging role of an immunomodulatory protein secretoglobin 3A2 in human diseases.

Pharmacol Ther

Biochemical Engineering, Graduate School of Science and Engineering, Yamagata University, Yonezawa, Yamagata 992-8510, Japan.

Published: August 2022

Secretoglobin (SCGB) 3A2 was first identified in 2001 as a protein exhibiting similarities in amino acid sequence and gene structure to SCGB1A1, a multi-functional cytokine-like molecule highly expressed in airway epithelial Club cells that was the first identified and extensively studied member of the SCGB gene superfamily. SCGB3A2 is a small secretory protein of ~10 kDa that forms a dimer and a tetramer. SCGB3A2 is predominantly expressed in airway epithelial Club cells, and has anti-inflammatory, growth factor, anti-fibrotic, and anti-cancer activities that influence various lung diseases. This review summarizes the current understanding of SCGB3A2 biological functions and its role in human diseases with emphasis on its mechanisms of actions and signaling pathway.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9271138PMC
http://dx.doi.org/10.1016/j.pharmthera.2022.108112DOI Listing

Publication Analysis

Top Keywords

human diseases
8
expressed airway
8
airway epithelial
8
epithelial club
8
club cells
8
emerging role
4
role immunomodulatory
4
immunomodulatory protein
4
protein secretoglobin
4
secretoglobin 3a2
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!